3 unknown. 3 Phase 1, 1 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Phase 1 | 3 | Unknown 3 |
| Phase 2 | 1 | Unknown 1 |
Follow poly ICLC: new trials by email Literature Review of poly ICLC trials Research Report on poly ICLC
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| A Phase I, Open-label Study to Assess the Safety and Efficacy of Poly-ICLC Plus Nivolumab in Unresectable Hepatocellular Carcinoma Patients Poly ICLC - Hepatocellular Carcinoma | Phase 1 | Unknown | National Taiwan University Hospital | 10 | 2021-10-01 | 2022-03-16 |
| Cyclophosphamide, Radiation Therapy, and Poly ICLC in Treating Patients With Unresectable, Recurrent, Primary, or Metastatic Liver Cancer cyclophosphamide, poly ICLC, hepatic artery embolization - Breast Cancer, Colorectal Cancer | Phase 1 / Phase 2 | Unknown | Rutgers, The State University of New Jersey | 50 | 2007-10-01 | 2014-01-14 |
| Safety Study to Test the Safety of HspE7 and Poly-ICLC Given in Patients With Cervical Intraepithelial Neoplasia HspE7 and Poly-ICLC - Cervical Intraepithelial Neoplasia | Phase 1 | Unknown | Nventa Biopharmaceuticals Corporation | 24 | 2007-05-01 | 2008-05-07 |
Carcinoma, Hepatocellular (2) · Breast Neoplasms (1) · Carcinoma, Ovarian Epithelial (1) · Colonic Neoplasms (1) · Colorectal Neoplasms (1) · Liver Neoplasms (1) · Melanoma (1) · Neoplasm Metastasis (1) · Ovarian Neoplasms (1) · Pancreatic Neoplasms (1) · Stomach Neoplasms (1) · Uterine Cervical Dysplasia (1)
National Taiwan University Hospital (1) · Nventa Biopharmaceuticals Corporation (1) · Rutgers, The State University of New Jersey (1)
United States (2) · Taiwan (1)